Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor.
Biology barrier
EGFR
GE11
Liposome
SMMC7721
Target delivery
Journal
Acta pharmaceutica Sinica. B
ISSN: 2211-3835
Titre abrégé: Acta Pharm Sin B
Pays: Netherlands
ID NLM: 101600560
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
10
04
2019
revised:
31
05
2019
accepted:
17
06
2019
entrez:
7
3
2020
pubmed:
7
3
2020
medline:
7
3
2020
Statut:
ppublish
Résumé
Liposomes, as one of the most successful nanotherapeutics, have a major impact on many biomedical areas. In this study, we performed laser scanning confocal microscope (LSCM) and immunohistochemistry (IHC) assays to investigate the intra-tumor transport and antitumor mechanism of GE11 peptide-conjugated active targeting liposomes (GE11-TLs) in SMMC7721 xenograft model. According to classification of individual cell types in high resolution images, biodistribution of macrophages, tumor cells, cells with high epidermal growth factor receptor (EGFR) expression and interstitial matrix in tumor microenvironment, in addition, their impacts on intra-tumor penetration of GE11-TLs were estimated. Type I collagen fibers and macrophage flooded in the whole SMMC7721 tumor xenografts. Tumor angiogenesis was of great heterogeneity from the periphery to the center region. However, the receptor-binding site barriers were supposed to be the leading cause of poor penetration of GE11-TLs. We anticipate these images can give a deep reconsideration for rational design of target nanoparticles for overcoming biological barriers to drug delivery.
Identifiants
pubmed: 32140398
doi: 10.1016/j.apsb.2019.06.011
pii: S2211-3835(19)30496-4
pmc: PMC7049609
doi:
Types de publication
Journal Article
Langues
eng
Pagination
546-556Informations de copyright
© 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
Références
Nanomedicine. 2016 Jan;12(1):143-61
pubmed: 26410277
Science. 2010 May 21;328(5981):1031-5
pubmed: 20378772
FASEB J. 2005 Dec;19(14):1978-85
pubmed: 16319141
Chem Rev. 2015 Oct 14;115(19):10938-66
pubmed: 26010257
Biochim Biophys Acta. 2016 Oct;1858(10):2334-2352
pubmed: 26915693
Br J Cancer. 2005 Jul 11;93(1):81-8
pubmed: 15942637
J Hepatol. 2004 Dec;41(6):1008-16
pubmed: 15582135
Elife. 2015 May 22;4:
pubmed: 25998055
Science. 2013 Feb 22;339(6122):971-5
pubmed: 23430657
Elife. 2017 Jan 19;6:
pubmed: 28100395
Curr Opin Chem Eng. 2015 Feb 1;7:65-74
pubmed: 25745594
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):28-51
pubmed: 26456916
Nanomedicine. 2015 Aug;11(6):1355-63
pubmed: 25839391
Drug Discov Today. 2006 Sep;11(17-18):812-8
pubmed: 16935749
Front Pharmacol. 2015 Dec 01;6:286
pubmed: 26648870
J Pharm Pharmacol. 2013 Feb;65(2):157-70
pubmed: 23278683
Nat Biotechnol. 2015 Sep;33(9):941-51
pubmed: 26348965
Sci Transl Med. 2017 Nov 29;9(418):
pubmed: 29187644
Cell Biol Int. 2015 Aug;39(8):881-90
pubmed: 25790433
J Control Release. 2015 Mar 10;201:78-89
pubmed: 25526702
Expert Rev Anticancer Ther. 2016 Jul;16(7):697-703
pubmed: 27219482
ACS Nano. 2017 Sep 26;11(9):9536-9549
pubmed: 28858473
J Control Release. 2017 May 28;254:92-106
pubmed: 28377038
Nanomedicine (Lond). 2011 Jun;6(4):715-28
pubmed: 21718180
Oncologist. 2015 Jun;20(6):660-73
pubmed: 26001391
Int J Pharm. 2006 Jan 3;307(1):93-102
pubmed: 16303268
Theranostics. 2013 Dec 11;4(1):81-9
pubmed: 24396516
J Control Release. 2019 Apr 28;300:73-80
pubmed: 30831135
J Control Release. 2012 Jun 10;160(2):117-34
pubmed: 22484195
Hepatology. 2014 Apr;59(4):1577-90
pubmed: 24677197
Adv Pharm Bull. 2015 Sep;5(3):305-13
pubmed: 26504751
Mol Pharm. 2014 Oct 6;11(10):3242-50
pubmed: 25181533
Mol Pharm. 2018 Jun 4;15(6):2069-2083
pubmed: 29767984
Int J Pharm. 2008 Nov 3;363(1-2):155-61
pubmed: 18692120
Curr Opin Immunol. 2015 Aug;35:107-12
pubmed: 26172292
Small. 2014 Jul 9;10(13):2516-29
pubmed: 24687857
Adv Drug Deliv Rev. 2013 Jan;65(1):36-48
pubmed: 23036225
Biomed Microdevices. 2018 Dec 3;20(4):105
pubmed: 30535532